Chancery Won't Delay Review Of Ionis Pharma Pay Suit Deal
An Ionis Pharmaceuticals Inc. shareholder has lost his bid to delay the Delaware Chancery Court's consideration of a proposed settlement that would resolve derivative claims lodged in litigation over alleged excessive...To view the full article, register now.
Already a subscriber? Click here to view full article